Related Experiment Video
Updated: Jul 19, 2026

Molecular Entanglement and Electrospinnability of Biopolymers
Published on: September 3, 2014
Intellectual property and biotechnology: the U.S. internal experience--Part II
1Center for Medical Ethics, Baylor College of Medicine, Houston, TX, USA.
Abstract:
Continuing the discussion begun in the March 2006 issue of the Kennedy Institute of Ethics Journal, this paper further documents the failure of the United States to adequately consider possible modifications in the traditional robust system of intellectual property rights as applied to biotechnology. It discusses concrete suggestions for alternative disclosure requirements, for exemptions for research tools, and for improved access to clinical advances. In each of these cases, the modifications might be more responsive to the full set of relevant values.
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Plant Breeding and Biotechnology
Production of Pharmaceuticals
Bioreactor Controls-III
The Central Dogma
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
Bioequivalence studies: Biowaivers
